Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 6, 2026 | -$1.75 | -$12.64 | Miss |
| Nov 1, 2025 | -$8.50 | -$12.25 | Miss |
| Jul 2, 2025 | -$8.50 | -$19.00 | Miss |
| Nov 20, 2024 | – | -$22.25 | |
| Aug 20, 2024 | – | -$42.75 | |
| Jan 12, 2024 | – | -$41.00 |